tbuckley/cabot-search huggingface dataset:
Splenectomy in Treatment of Hemorrhagic Conditions.
Journal: JAMA (1924)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
THE METHODIC DESCRIPTION OF A SURGICAL DISEASE.
Authors: EDMOND SOUCHON
Journal: JAMA (1896)

<h3>FORMS, VARIETIES, COMPLICATIONS AND RECURRENCES.</h3> The description of the forms, varieties and complications of the disease comprises that of all the points and features which are not commonly met with and the description of which would embarrass or obscure the description of the most common or frequent appearance of the disease. Those forms, varieties and complications must be stated as due to peculiar causes; to pathologic peculiarities, to peculiar symptoms, course, termination, duration, diagnosis, prognosis, complications, relapses, sequelæ or consequences. Complications may be local or regional or general. The local and regional complications may be due to malformation, to softening, induration, neurosis, injury, congestion, inflammation, gangrene, ulcer, fistula, tumor; they may affect the skin, connective tissue, adipose tissue, tendons, muscles, fascia, periosteum, bones, medulla, arteries, veins, capillaries, lymphatic vessels, lymphatic glands, nerves, an organ special to the region. The general complications may affect the organs of circulation, respiration, etc. For
EPIDEMIC PLEURODYNIA
Authors: ARTHUR B. RICHTER
Journal: JAMA (1934)

During July, August and September 1933, twenty-four cases of epidemic pleurodynia, or "devil's grip," were admitted to the Peter Bent Brigham Hospital and are typical of cases reported in the literature, as well as of those seen at other Boston hospitals<sup>1</sup>and by numerous physicians in private practice in Boston during the same period. The first outbreak of epidemic pleurodynia was reported in Virginia in 1888 by Dabney.<sup>2</sup>Since that time epidemics have been reported in New York City in 1923,<sup>3</sup>a second one in Virginia in 1923,<sup>4</sup>in Philadelphia and New Jersey in 1924,<sup>5</sup>and in Tennessee<sup>6</sup>and Massachusetts in 1925.<sup>7</sup>As described in the literature,<sup>8</sup>the condition is characterized by the abrupt onset of excruciating pain in the chest or the epigastrium, aggravated by breathing or by movement of the trunk; tenderness, generally over the site of pain; an accompanying
MASSAGE IN GYNECOLOGY OSCAR J. MAYER, M.D.
Journal: JAMA (1994)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
JAMES TILTON (1745-1822) PHYSICIAN OF THE REVOLUTIONARY WAR
Journal: JAMA (1966)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Global differences in cancer drug prices: A comparative analysis.
Authors: Daniel A. Goldstein, Jonathon Clark, Yifan Tu, Jie Zhang, Fenqi Fang, Robert Michael Goldstein, Salomon M. Stemmer, Eli Rosenbaum
Journal: Journal of Clinical Oncology (2016)

LBA6500 The full, final text of this abstract will be available at abstracts.asco.org at 7:30 AM (EDT) on Monday, June 6, 2016, and in the Annual Meeting Proceedings online supplement to the June 20, 2016, issue of the Journal of Clinical Oncology. Onsite at the Meeting, this abstract will be printed in the Monday edition of ASCO Daily News.
Richard Morton (1637-1698)
Journal: JAMA (1969)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
What's new in the other general journals
Authors: Alison Tonks
Journal: BMJ (2005)

After observational studies hinted that drinking coffee reduced the risk of type 2 diabetes, researchers investigated this attractive possibility by systematically reviewing the best available data. They found a strong and consistent link between habitual coffee drinking and a lower incidence of type 2 diabetes. In nine cohort studies combined (n = 193 473) people in the highest or second highest categories for coffee drinking (3 6 cups/day and 4-6 cups/day) were about a third less likely to develop diabetes than people in the lowest category (£ 2 cups/day) (relative risks 0.65, 95% confidence interval 0.54 to 0.78, and 0.72, 0.62 to 0.83). The association stood firm after adjustment for confounding factors, including smoking and obesity. It was also consistent across five cross sectional studies from Japan, Spain, Sweden, and the Netherlands. Credit: LANCET These findings look convincing, but it's much too early to start telling patients to drink more coffee, say the authors. Because of the nature of the studies, there's still a chance the association isn't real (caused instead by bias or confounding) or causal (early diabetes might alter coffee drinking habits). Even if it is both, we need to find out more about how and why coffee alters glucose metabolism before concluding that it's good prophylaxis against diabetes. JAMA 2005; 294: 97–104 [OpenUrl][1][CrossRef][2][PubMed][3][Web of Science][4] One or two intramuscular injections of long acting chloramphenicol is the cornerstone of treatment for epidemic meningococcal meningitis in sub-Saharan Africa. It's cheap, effective, and easy to use, but production, and therefore supply, is under threat. Ceftriaxone is another widely available antibiotic with activity against Neisseria meningitidis , and it has been found to work just as well in a recent head to head trial from Niger. The trial, which was randomised but not blinded because of technical difficulties in the field, compared single injections of ceftriaxone or chloramphenicol … [1]: {openurl}?query=rft.jtitle%253DJAMA%26rft.stitle%253DJAMA%26rft.issn%253D0002-9955%26rft.aulast%253Dvan%2BDam%26rft.auinit1%253DR.%2BM.%26rft.volume%253D294%26rft.issue%253D1%26rft.spage%253D97%26rft.epage%253D104%26rft.atitle%253DCoffee%2BConsumption%2Band%2BRisk%2Bof%2BType%2B2%2BDiabetes%253A%2BA%2BSystematic%2BReview%26rft_id%253Dinfo%253Adoi%252F10.1001%252Fjama.294.1.97%26rft_id%253Dinfo%253Apmid%252F15998896%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx [2]: /lookup/external-ref?access_num=10.1001/jama.294.1.97&link_type=DOI [3]: /lookup/external-ref?access_num=15998896&link_type=MED&atom=%2Fbmj%2F331%2F7509%2F131.atom [4]: /lookup/external-ref?access_num=000230210200030&link_type=ISI
Changing the medical school curriculum to improve patient access to primary care
Authors: J. E. Verby
Journal: JAMA (1991)

The problems of access to health care by the underinsured demand a systematic response. One of the critical components of that response is medical curriculum reform, with the intent to graduate adequate numbers of physicians to do primary care, to work with the underinsured and the uninsured, and to practice in rural areas. One state, Minnesota, has developed a unique response to these needs, demonstrating problem solving very much in keeping with many of the recommendations in the literature. Highlighted in this article is the University of Minnesota's Rural Physician Associate Program, a predoctoral curriculum innovation functioning for 20 years to help resolve the issue of physician maldistribution in the state. The Rural Physician Associate Program provides students with many of the skills needed to provide primary care, it is cost-effective, and it has brought a number of benefits to the participating communities. (<i>JAMA</i>. 1991;266:110-113)
Sex, splenectomy, and myeloid metaplasia
Authors: M. N. Silverstein
Journal: JAMA (1974)

Over the last decade, 29 patients with agnogenic myeloid metaplasia had splenectomies. Indications for splenectomy included hemolytic anemia, thrombocytopenia, mechanical splenomegaly, and portal hypertension. The 13 women tended to be younger when splenectomized, had a longer duration of illness before splenectomy, and had the procedure for pressure symptoms, thrombocytopenia, or portal hypertension. Fifty percent of the men had serious postoperative complications, compared with only 23% of the women; 50% of the women survived at least five years after the procedure, whereas only two men are living two years after the procedure, and 14 have died within an average of two years after splenectomy.
Intramuscular hemangioma
Authors: A. J. Cohen
Journal: JAMA (1983)

In two cases of intramuscular hemangioma of the paraspinous muscles, the tumors were treated with arteriographic embolization followed by immediate local excision. We found that this technique creates a hypovascular surgical field and facilitates the dissection. We believe this approach will decrease morbidity and potential mortality. (<i>JAMA</i>1983;249:2680-2682)
Marriages
Journal: JAMA (1918)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Cryptogenic Stroke
Authors: J.P. Mohr
Journal: New England Journal of Medicine (1988)

IN this issue of the Journal, Lechat and colleagues1 show that contrast echocardiography greatly increased the frequency with which patent foramen ovale was diagnosed in a series of young patients who had had strokes, especially in a subgroup with no known risk factors for stroke. These findings point up the value of noninvasive cardiac imaging in uncovering a risk factor in those whose stroke would otherwise be characterized as "cryptogenic." The diagnosis of cryptogenic stroke is more common, now that atherosclerotic stenosis or thrombosis of large arteries, formerly the accepted causes of a majority of strokes, have been shown . . .
Social Medicine, Medical Economics and Miscellany
Journal: JAMA (1918)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Clitoridectomy
Authors: F. Winslow
Journal: BMJ (1866)

<b>Background and Objective:</b> Although lung cancer mainly occur in the middle-old age population, a considerable proportion of lung cancer occur in the young population. Our aim is to investigate the clinicopathological characteristics and prognosis of young patients with non-small cell lung cancer (NSCLC). <b>Methods:</b> A cohort of 5320 patients with primary NSCLC were include and were classified into four groups: young group (≤ 45 years), middle-young group (46-60 years), middle-old group (61-75 years) and old group (≥76 years). We compared the clinicopathological features, treatment approaches and overall survival (OS) of the patients among different age groups. <b>Results:</b> Patients in the young group accounted for 12.1% of all NSCLC cases. The proportions of female, never-smoker and adenocarcinoma were 49.9%, 65.9% and 74.0% in the young group, higher than those in the other three age groups (p＜0.001 for all). And the proportion of III/IV stage tumor was 84.3% in the young group, just less than that in the old group (87.9%；p＜0.001). Patients in young group were more likely to receive surgery (30.5%) and chemotherapy (38.9%), and got comparatively favorable OS compared with the patients in the other three age groups (p＞0.05 for all). <b>Conclusions:</b> Young patients with NSCLC had unique clinicopathological characteristics, with more females, never-smokers and adenocarcinomas. Although young patients with NSCLC were more likely to have III/IV stage tumor, they may choose aggressive treatment approaches, such as surgery and chemotherapy, thus got a comparatively favorable prognosis.
Manuscripts Approved for JNCI During May-June 1976
Journal: JNCI Journal of the National Cancer Institute (1976)

Journal Article Manuscripts Approved for JNCI During May-June 1976 Get access JNCI: Journal of the National Cancer Institute, Volume 57, Issue 1, July 1976, Pages 227–229, https://doi.org/10.1093/jnci/57.1.227-d Published: 01 July 1976
Comparative Risk for Angioedema Associated With the Use of Drugs That Target the Renin-Angiotensin-Aldosterone System
Authors: Sengwee Toh, Marsha E. Reichman, Monika Houstoun, Mary Ross Southworth, Xiao Ding, Adrian F. Hernandez, Mark Levenson, Lingling Li, Carolyn McCloskey, Azadeh Shoaibi, Eileen Wu, Gwen Zornberg, Sean Hennessy
Journal: JAMA Internal Medicine (2012)
Abstract 313: An Akt3 splice variant lacking the serine 472 phosphorylation site promotes apoptosis and suppresses mammary tumorigenesis
Authors: Rachel B. Hazan
Journal: Cancer Research (2018)

Abstract The Akt pathway is a well-known promoter of tumor malignancy. Akt3 is expressed as two alternatively spliced variants, one of which lacks the key regulatory serine 472 phosphorylation site. Whereas the function of full-length Akt3 isoform (Akt3/+S472) is well-characterized, that of Akt3/-S472 isoform remains unknown. Despite being expressed at a substantially lower level than Akt3/+S472 in triple negative breast cancer cells, specific ablation of Akt3/-S472, enhanced, whereas overexpression, suppressed mammary tumor growth-consistent with a significant association with patient survival duration relative to Akt3/+S472. These effects were due to striking induction of apoptosis, which was mediated by Bim upregulation, leading to conformational activation of Bax and caspase-3 processing. Bim accumulation was caused by marked endocytosis of EGF receptors with concomitant ERK attenuation, which stabilizes BIM. These findings demonstrate an unexpected function of an endogenously expressed Akt isoform in promoting - as opposed to suppressing - apoptosis, underscoring that Akt isoforms may exert dissonant functions in malignancy.&amp;lt;!–EndFragment–&amp;gt; Citation Format: Rachel B. Hazan. An Akt3 splice variant lacking the serine 472 phosphorylation site promotes apoptosis and suppresses mammary tumorigenesis [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2018; 2018 Apr 14-18; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2018;78(13 Suppl):Abstract nr 313.
"ELEVATION OF CONJUNCTIVA NEAR LIMBUS PREVIOUS TO CATARACT EXTRACTION"
Journal: JAMA (1920)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal